Biovail’s Tramadol ER Approved Without Additional Clinical Studies
This article was originally published in The Pink Sheet Daily
Executive Summary
The company expects the analgesic to launch early in 2006, but continues negotiations over a marketing partnership.
You may also be interested in...
Cipher Submits New Tramadol NDA
Move could trigger legal action over patents, the company warns.
Cipher Submits New Tramadol NDA
Move could trigger legal action over patents, the company warns.
Labopharm’s Painful FDA Experience Continues
Canadian firm receives second “approvable” for once-daily analgesic tramadol, may pursue dispute resolution filed in December.